Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294981 · ClinicalTrials.gov registry record · NA
Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02294981 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 4 participants.
The verdict
NCT02294981, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the best dosing strategy when using Excimer Laser to treat plaque-type psoriasis. In this study, half of the body's psoriasis will be treated with a new dosing strategy, and the other half will be treated with the conventional method. We hope to show that the new dosing strategy will result in faster improvement of psoriasis.
Interventions
- DEVICE Excimer laser phototherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02294981
The ClinicalTrials.gov registry entry for NCT02294981 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Excimer laser phototherapy is the first listed.
NCT02294981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02294981 about?
NCT02294981 is a clinical study titled "Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis". The purpose of this study is to determine the best dosing strategy when using Excimer Laser to treat plaque-type psoriasis. In this study, half of the body's psoriasis will be treated with a new dosing strategy, and the other half will be treated with the conventional method. We hope to show that th...
What is the current status of trial NCT02294981?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-01. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02294981?
The interventions under investigation include: Excimer laser phototherapy (DEVICE).
Who is sponsoring clinical trial NCT02294981?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.